Paul Stellato

Interim Chief Financial Officer and Vice President, Controller and Chief Accounting Officer · Zimmer Biomet Holdings

Medical Devices

Paul Stellato is interim chief financial officer and vice president, controller and chief accounting officer of Zimmer Biomet Holdings. His career includes public accounting, audit and investor relations at ITT, and several finance leadership roles at Xylem.

Last reviewed: Nov 4, 2026

Paul Stellato

Interim Chief Financial Officer and Vice President, Controller and Chief Accounting Officer
Zimmer Biomet Holdings

Last Reviewed: November 4, 2026

Executive Summary

Paul Stellato is interim chief financial officer and vice president, controller and chief accounting officer of Zimmer Biomet Holdings. His career includes public accounting, audit and investor relations at ITT, and several finance leadership roles at Xylem.

Career Highlights

  • Joined ITT in May 2003 and moved to Xylem when it separated from ITT in October 2011.
  • Advanced through Xylem planning, controllership and global business services finance roles.
  • Joined Zimmer Biomet in May 2022 and added interim CFO responsibilities in April 2026.

Professional Journey

Stellato began his career in public accounting at Arthur Andersen and Ernst & Young. In May 2003, he joined ITT, where he advanced through finance positions including manager of Investor Relations and, subsequently, general auditor.

He moved to Xylem when it separated from ITT in October 2011. At the water technology company, he served as vice president of Finance for Financial Planning and Analysis through August 2017. He also became interim corporate controller in August 2016 before being promoted to vice president, controller and chief accounting officer in August 2017.

In March 2019, Stellato became Xylem’s vice president of Finance for Global Business Services, a position he held through April 2022. He then joined Zimmer Biomet in May 2022 as vice president, controller and chief accounting officer. His responsibilities later included heading corporate financial planning and analysis.

Stellato added interim chief financial officer responsibilities in April 2026 following Suketu Upadhyay’s departure. He continues to hold the controller and chief accounting officer positions. His work at Zimmer Biomet has included capital allocation associated with acquisitions and the company’s share repurchase program.

Education

Stellato holds a BS in accountancy from Villanova University and an MBA in finance from NYU Stern. He is a certified public accountant.